Roche Holding AG Stock Swiss Exchange
Stocks
ROG
CH0012032048
Pharmaceuticals
OTC Markets Traded| Market Cap | 291B 351B 309B 266B 496B 33,723B 501B 3,486B 1,353B 17,196B 1,320B 1,291B 55,737B | P/E 2026 * |
19.8x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 302B 364B 320B 275B 515B 34,982B 519B 3,616B 1,403B 17,838B 1,369B 1,339B 57,818B | EV / Sales 2026 * |
4.81x | EV / Sales 2027 * | 4.5x |
| Free-Float |
88.78% | Yield 2026 * |
2.75% | Yield 2027 * | 2.82% |
Last Transcript: Roche Holding AG
| 1 day | -1.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.35% | +2.01% | - | - | 352B | ||
| +2.68% | +3.87% | +58.22% | +114.68% | 1,026B | ||
| +0.56% | +1.27% | +53.29% | +68.65% | 649B | ||
| +0.02% | +0.99% | +19.10% | +73.58% | 468B | ||
| +0.06% | +0.25% | +37.03% | +45.71% | 352B | ||
| +1.16% | +4.10% | +21.99% | +29.39% | 271B | ||
| -0.24% | +2.18% | +10.14% | +12.26% | 256B | ||
| -0.01% | +7.89% | +41.57% | +51.68% | 220B | ||
| -1.11% | +1.36% | +30.85% | +99.56% | 188B | ||
| +0.30% | -7.19% | -32.43% | -60.56% | 170B | ||
| Average | -0.06% | +1.26% | +26.64% | +48.33% | 399.9B | |
| Weighted average by Cap. | +0.02% | +1.26% | +37.30% | +67.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.66B 75.63B 66.47B 57.22B 107B 7,266B 108B 751B 291B 3,705B 284B 278B 12,009B | 65.47B 79.03B 69.46B 59.79B 112B 7,593B 113B 785B 305B 3,872B 297B 291B 12,549B |
| Net income | 14.51B 17.51B 15.39B 13.25B 24.76B 1,682B 24.97B 174B 67.48B 858B 65.83B 64.39B 2,780B | 16.33B 19.71B 17.32B 14.91B 27.87B 1,894B 28.11B 196B 75.96B 966B 74.11B 72.49B 3,130B |
| Net Debt | 10.86B 13.11B 11.52B 9.92B 18.54B 1,259B 18.7B 130B 50.52B 642B 49.28B 48.21B 2,081B | 3.99B 4.82B 4.24B 3.65B 6.82B 463B 6.88B 47.88B 18.58B 236B 18.13B 17.73B 766B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















